Tuesday, March 31, 2015

Temple, Texas: Unique Pharmaceuticals, a 503B outsourcing facility, today announced its operational transformation is complete and the company has initiated sterile compounding operations meeting the newly established federal guidelines.

  1. Unique Pharmaceuticals Launches Sterile Operations under New ...

    PR Newswire (press release)-16 minutes ago
    Passage of the DQSA brought definition to the regulation of the compounding industry by establishing a new oversight section of the FDA for "outsourcing ...

No comments: